These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 33231360)
41. Association between hypertension and neurovascular inflammation in both normal-appearing white matter and white matter hyperintensities. Solé-Guardia G; Custers E; de Lange A; Clijncke E; Geenen B; Gutierrez J; Küsters B; Claassen JAHR; de Leeuw FE; Wiesmann M; Kiliaan AJ Acta Neuropathol Commun; 2023 Jan; 11(1):2. PubMed ID: 36600303 [TBL] [Abstract][Full Text] [Related]
42. Deep microbleeds and periventricular white matter disintegrity are independent predictors of attention/executive dysfunction in non-dementia patients with small vessel disease. Cao WW; Wang Y; Dong Q; Chen X; Li YS; Zhou Y; Gao L; Deng Y; Xu Q Int Psychogeriatr; 2017 May; 29(5):793-803. PubMed ID: 27938433 [TBL] [Abstract][Full Text] [Related]
43. Abnormal frontostriatal tracts in young male tobacco smokers. Yuan K; Yu D; Zhao M; Li M; Wang R; Li Y; Manza P; Shokri-Kojori E; Wiers CE; Wang GJ; Tian J Neuroimage; 2018 Dec; 183():346-355. PubMed ID: 30130644 [TBL] [Abstract][Full Text] [Related]
44. Superficial white matter microstructure affects processing speed in cerebral small vessel disease. Wang S; Zhang F; Huang P; Hong H; Jiaerken Y; Yu X; Zhang R; Zeng Q; Zhang Y; Kikinis R; Rathi Y; Makris N; Lou M; Pasternak O; Zhang M; O'Donnell LJ Hum Brain Mapp; 2022 Dec; 43(17):5310-5325. PubMed ID: 35822593 [TBL] [Abstract][Full Text] [Related]
45. Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-Up. Cai M; Jacob MA; van Loenen MR; Bergkamp M; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE Stroke; 2022 Sep; 53(9):2789-2798. PubMed ID: 35506383 [TBL] [Abstract][Full Text] [Related]
46. Effects of amyloid and small vessel disease on white matter network disruption. Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100 [TBL] [Abstract][Full Text] [Related]
47. Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease. Bergkamp MI; Tuladhar AM; van der Holst HM; van Leijsen EMC; Ghafoorian M; van Uden IWM; van Dijk EJ; Norris DG; Platel B; Esselink RAJ; Leeuw FE Parkinsonism Relat Disord; 2019 Apr; 61():94-100. PubMed ID: 30448096 [TBL] [Abstract][Full Text] [Related]
48. Oxygen Metabolic Stress and White Matter Injury in Patients With Cerebral Small Vessel Disease. Kang P; Ying C; Chen Y; Ford AL; An H; Lee JM Stroke; 2022 May; 53(5):1570-1579. PubMed ID: 34886686 [TBL] [Abstract][Full Text] [Related]
49. Neural Substrates of Psychomotor Speed Deficits in Cerebral Small Vessel Disease: A Brain Disconnectome Mapping Study. da Silva PHR; de Leeuw FE; Zotin MCZ; Neto OMP; Leoni RF; Tuladhar AM Brain Topogr; 2023 Jul; 36(4):545-553. PubMed ID: 37156893 [TBL] [Abstract][Full Text] [Related]
50. Synergistic associations of cognitive and motor impairments with functional outcome in covert cerebral small vessel disease. Jokinen H; Laakso HM; Ahlström M; Arola A; Lempiäinen J; Pitkänen J; Paajanen T; Sikkes SAM; Koikkalainen J; Lötjönen J; Korvenoja A; Erkinjuntti T; Melkas S Eur J Neurol; 2022 Jan; 29(1):158-167. PubMed ID: 34528346 [TBL] [Abstract][Full Text] [Related]
51. Baseline white matter hyperintensities affect the course of cognitive function after small vessel disease-related stroke: a prospective observational study. Fruhwirth V; Enzinger C; Fandler-Höfler S; Kneihsl M; Eppinger S; Ropele S; Schmidt R; Gattringer T; Pinter D Eur J Neurol; 2021 Feb; 28(2):401-410. PubMed ID: 33065757 [TBL] [Abstract][Full Text] [Related]
52. Executive dysfunction correlates with caudate nucleus atrophy in patients with white matter changes on MRI: a subset of LADIS. Macfarlane MD; Looi JC; Walterfang M; Spulber G; Velakoulis D; Crisby M; Orndahl E; Erkinjuntti T; Garde E; Waldemar G; Wallin A; Wahlund LO; Psychiatry Res; 2013 Oct; 214(1):16-23. PubMed ID: 23916538 [TBL] [Abstract][Full Text] [Related]
53. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults. Jung Y; Viviano RP; van Rooden S; van der Grond J; Rombouts SARB; Damoiseaux JS J Alzheimers Dis; 2021; 84(3):1337-1350. PubMed ID: 34657884 [TBL] [Abstract][Full Text] [Related]
54. Intravoxel Incoherent Motion Imaging in Small Vessel Disease: Microstructural Integrity and Microvascular Perfusion Related to Cognition. Zhang CE; Wong SM; Uiterwijk R; Staals J; Backes WH; Hoff EI; Schreuder T; Jeukens CR; Jansen JF; van Oostenbrugge RJ Stroke; 2017 Mar; 48(3):658-663. PubMed ID: 28196940 [TBL] [Abstract][Full Text] [Related]
55. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease. Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y Front Immunol; 2021; 12():803504. PubMed ID: 34956241 [TBL] [Abstract][Full Text] [Related]
56. The association between white matter hyperintensity volume and cognitive/physical decline in older people with dementia: A one-year longitudinal study. Hairu R; Close JCT; Lord SR; Delbaere K; Wen W; Jiang J; Taylor ME Aging Ment Health; 2022 Dec; 26(12):2503-2510. PubMed ID: 34569854 [TBL] [Abstract][Full Text] [Related]
57. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline. Nolze-Charron G; Mouiha A; Duchesne S; Bocti C; J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625 [TBL] [Abstract][Full Text] [Related]